Our Commitment

Farbridge Pharma Consulting wants everyone who visits farbridgepharma.com to be able to learn about our services, read our insights and contact our team, including people who use assistive technologies such as screen readers, screen magnifiers, speech recognition or a keyboard instead of a mouse.

We use the Web Content Accessibility Guidelines (WCAG) 2.1 at Level AA, published by the World Wide Web Consortium (W3C), as the standard this website is designed, built and tested against. This statement explains what has been tested so far, what we know still needs attention, and how to tell us about a problem.

How This Website Has Been Evaluated

This website is built and maintained for us by Dux Prana, a web accessibility agency. Dux Prana evaluates it with its own testing tool, which opens each page it finds in English, Spanish and French in the Chromium browser and checks it against the WCAG 2.1 Level A and AA success criteria. The evaluation includes:

• automated checks with the open-source axe-core engine on a desktop view, on a 320-pixel-wide mobile view with the menu open, with accordions and tabs expanded, and in dark mode;
• a walk through each page with the Tab key, checking that keyboard focus is visible, follows a logical order and never gets trapped;
• layout checks at 320 pixels wide, at 200% text size and with increased letter, word and line spacing;
• checks of form labels and error messages, moving content, page titles and the language of each page.

The most recent evaluation, on 15 October 2026, covered 120 pages of a pre-release build of this website. It marked 48 of the 50 WCAG 2.1 Level A and AA success criteria for a person to check, because automated tools cannot judge them on their own: for example, whether a text alternative describes its image well. That manual review has not been completed yet. Automated testing cannot show by itself that a website meets WCAG 2.1 Level AA, so this statement reports what has been tested and does not claim that the website meets the standard.

Known Limitations

• Manual review. The manual part of the evaluation described above is not complete, so there may be barriers that have not been found yet.
• GxP Academy and account pages. The GxP Academy course pages (catalogue, course, player, dashboard and certificate) and the sign-in and registration pages were not part of the 15 October 2026 evaluation.
• Terms dialog and privacy choices. The dialog that asks you to accept our Terms of Service on your first visit, and the privacy choices that open from “Your Privacy Choices” at the bottom of each page, were added after that evaluation and will be included in the next one.
• Third-party services. GxP Academy course videos play in the Vimeo player. This service is provided by another company, and we cannot fully control how accessible it is. If it causes you difficulty, contact us and we will look for another way to help.

Technologies This Website Relies On

This website relies on HTML, CSS, JavaScript and WAI-ARIA to work with your web browser and any assistive technology you use. Some features, such as site search and the forms, need JavaScript to be turned on.

Feedback and Contact

If you have difficulty using any part of this website, or you need information from it in another format, please tell us. It helps if you include the web address (URL) of the page, what you were trying to do, and the browser and any assistive technology you were using.

Email us at info@farbridgepharma.com or write to us through our contact page.

This statement was prepared in October 2026, based on the evaluation of 15 October 2026.